GNP-101

N/A

Report date: 2025/01/26 15:51:41

Base Information

Drug NameGNP-101
Drug Alias Nameanti-HER2/IFN-beta immunocytokines (Seoul National University/Genopharm)GNP-101
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionInterferon alpha/beta receptor agonistsReceptor protein-tyrosine kinase erbB-2 modulators
TargetsReceptor protein-tyrosine kinase erbB-2Interferon alpha/beta receptor
Therapy Area/IndicationsStomach NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSeoul National University
China Registration ClassN/A

Develop Information

Active CompaniesGenopharm IncSeoul National University
Inactive CompaniesN/A
Active IndicationsStomach NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A